Friday, 20 October 2017
[Source: Research & Innovation] EU and industry-funded research into validating more imaging biomarkers for use in cancer drug trials seeks to speed up development of successful new drugs and avoid exposing patients to treatment that does not work for them.
What's New in Innovation
A pocket guide on the Innovation Union
Europe's future is connected to its power to innovate. The Innovation Union, an action-packed initiative for an innovation-friendly Europe, is the solution.
Click on any country in the map below to view its research and innovation performance.
Innovation Union progress at country level 2014
24 October 2017
Complying with art. 32 of the H2020 multi-beneficiary grant agreement, this event addresses all beneficiaries and potential applicants of H2020 contracts/projects who need to comply with article 32 stipulating the need to take measures to implement the European Charter and Code (C & C) for the benefit of all researchers and their institution.
The purpose of the event is to fully inform ‘newcomers’ (research performing and research funding organisations) on the principles of Charter and Code and their implementation as recommended in H2020 multi-beneficiary Grant Agreement.
The structured implementation of the C&C principles via the Human Resources Strategy for Researchers (HRS4R) to comply with art 32 will be explained by DG RTD; successful implementation is awarded by the Commission Services and evidences a first step towards compliance with article 32 of the H2020 grant agreement.